1:"$Sreact.fragment"
2:I[82104,["6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","2926","static/js/2926.76e4f620.js","8173","static/js/8173.582c8c90.js","9756","static/js/9756.65c7d9ea.js","5246","static/js/5246.d88343e0.js","7177","static/js/app/layout.2233f7cc.js"],"default"]
3:I[17146,["6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","2926","static/js/2926.76e4f620.js","8173","static/js/8173.582c8c90.js","9756","static/js/9756.65c7d9ea.js","5246","static/js/5246.d88343e0.js","7177","static/js/app/layout.2233f7cc.js"],"AuthProvider"]
4:I[63612,["6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","2926","static/js/2926.76e4f620.js","8173","static/js/8173.582c8c90.js","9756","static/js/9756.65c7d9ea.js","5246","static/js/5246.d88343e0.js","7177","static/js/app/layout.2233f7cc.js"],"SearchProvider"]
5:I[68998,["6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","2926","static/js/2926.76e4f620.js","8173","static/js/8173.582c8c90.js","9756","static/js/9756.65c7d9ea.js","5246","static/js/5246.d88343e0.js","7177","static/js/app/layout.2233f7cc.js"],"default"]
6:I[98904,["6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","2926","static/js/2926.76e4f620.js","8173","static/js/8173.582c8c90.js","9756","static/js/9756.65c7d9ea.js","5246","static/js/5246.d88343e0.js","7177","static/js/app/layout.2233f7cc.js"],"default"]
7:I[15244,[],""]
8:I[43866,[],""]
9:I[14046,["6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","2926","static/js/2926.76e4f620.js","8173","static/js/8173.582c8c90.js","9756","static/js/9756.65c7d9ea.js","5246","static/js/5246.d88343e0.js","7177","static/js/app/layout.2233f7cc.js"],"ToastContainer"]
b:I[86213,[],"OutletBoundary"]
d:I[86213,[],"MetadataBoundary"]
f:I[86213,[],"ViewportBoundary"]
11:I[34835,[],""]
:HL["/search/_next/static/media/47cbc4e2adbc5db9-s.p.woff2","font",{"crossOrigin":"","type":"font/woff2"}]
:HL["/search/_next/static/media/e4af272ccee01ff0-s.p.woff2","font",{"crossOrigin":"","type":"font/woff2"}]
:HL["/search/_next/static/css/a38392bd344718e4.css","style"]
:HL["/search/_next/static/css/4921cfd18b262f8c.css","style"]
0:{"P":null,"b":"0Pw2B2A-ctu_hDkpgRDyX","p":"/search","c":["","items","synthetic-dataset-hospitalised-patients-with-thromboembolic-diagnosis"],"i":false,"f":[[["",{"children":["items",{"children":[["slug","synthetic-dataset-hospitalised-patients-with-thromboembolic-diagnosis","d"],{"children":["__PAGE__",{}]}]}]},"$undefined","$undefined",true],["",["$","$1","c",{"children":[[["$","link","0",{"rel":"stylesheet","href":"/search/_next/static/css/a38392bd344718e4.css","precedence":"next","crossOrigin":"$undefined","nonce":"$undefined"}]],["$","html",null,{"lang":"en","children":[["$","head",null,{"children":["$","meta",null,{"name":"emotion-insertion-point","content":""}]}],["$","body",null,{"className":"__className_55b4bf","children":["$","$L2",null,{"children":["$","$L3",null,{"children":["$","$L4",null,{"children":[["$","$L5",null,{"sx":{"display":"flex","flexDirection":{"xs":"column","md":"row"}},"children":[["$","$L6",null,{}],["$","$L5",null,{"component":"main","sx":{"flexGrow":1,"ml":{"xs":0,"md":"72px"},"mt":{"xs":"64px","md":0},"minHeight":{"xs":"calc(100vh - 64px)","md":"100vh"},"width":{"xs":"100%","md":"calc(100% - 72px)"}},"children":["$","$L7",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L8",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":[[],[["$","title",null,{"children":"404: This page could not be found."}],["$","div",null,{"style":{"fontFamily":"system-ui,\"Segoe UI\",Roboto,Helvetica,Arial,sans-serif,\"Apple Color Emoji\",\"Segoe UI Emoji\"","height":"100vh","textAlign":"center","display":"flex","flexDirection":"column","alignItems":"center","justifyContent":"center"},"children":["$","div",null,{"children":[["$","style",null,{"dangerouslySetInnerHTML":{"__html":"body{color:#000;background:#fff;margin:0}.next-error-h1{border-right:1px solid rgba(0,0,0,.3)}@media (prefers-color-scheme:dark){body{color:#fff;background:#000}.next-error-h1{border-right:1px solid rgba(255,255,255,.3)}}"}}],["$","h1",null,{"className":"next-error-h1","style":{"display":"inline-block","margin":"0 20px 0 0","padding":"0 23px 0 0","fontSize":24,"fontWeight":500,"verticalAlign":"top","lineHeight":"49px"},"children":404}],["$","div",null,{"style":{"display":"inline-block"},"children":["$","h2",null,{"style":{"fontSize":14,"fontWeight":400,"lineHeight":"49px","margin":0},"children":"This page could not be found."}]}]]}]}]]],"forbidden":"$undefined","unauthorized":"$undefined"}]}]]}],["$","$L9",null,{"position":"bottom-right"}]]}]}]}]}]]}]]}],{"children":["items",["$","$1","c",{"children":[null,["$","$L7",null,{"parallelRouterKey":"children","segmentPath":["children","items","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L8",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","forbidden":"$undefined","unauthorized":"$undefined"}]]}],{"children":[["slug","synthetic-dataset-hospitalised-patients-with-thromboembolic-diagnosis","d"],["$","$1","c",{"children":[null,["$","$L7",null,{"parallelRouterKey":"children","segmentPath":["children","items","children","$0:f:0:1:2:children:2:children:0","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L8",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","forbidden":"$undefined","unauthorized":"$undefined"}]]}],{"children":["__PAGE__",["$","$1","c",{"children":["$La",[["$","link","0",{"rel":"stylesheet","href":"/search/_next/static/css/4921cfd18b262f8c.css","precedence":"next","crossOrigin":"$undefined","nonce":"$undefined"}]],["$","$Lb",null,{"children":"$Lc"}]]}],{},null,false]},null,false]},null,false]},null,false],["$","$1","h",{"children":[null,["$","$1","2w7DL3x0lW7WVQWQ17Ypd",{"children":[["$","$Ld",null,{"children":"$Le"}],["$","$Lf",null,{"children":"$L10"}],["$","meta",null,{"name":"next-size-adjust","content":""}]]}]]}],false]],"m":"$undefined","G":["$11","$undefined"],"s":false,"S":true}
12:I[53704,["3524","static/js/2170a4aa.3678665e.js","6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","1057","static/js/1057.fef3cc4c.js","2282","static/js/2282.e20001b9.js","9234","static/js/9234.7cf96505.js","2926","static/js/2926.76e4f620.js","7511","static/js/7511.a52b23cb.js","8173","static/js/8173.582c8c90.js","613","static/js/613.da2777c4.js","9756","static/js/9756.65c7d9ea.js","97","static/js/97.c5459b6e.js","2649","static/js/2649.4d01838c.js","1857","static/js/1857.a01744c0.js","280","static/js/280.07f8eb1b.js","9123","static/js/9123.0b9c8079.js","6387","static/js/app/items/%5Bslug%5D/page.e8e51342.js"],""]
14:I[5749,["3524","static/js/2170a4aa.3678665e.js","6586","static/js/6586.2e946dbf.js","4889","static/js/4889.4efc83ef.js","1057","static/js/1057.fef3cc4c.js","2282","static/js/2282.e20001b9.js","9234","static/js/9234.7cf96505.js","2926","static/js/2926.76e4f620.js","7511","static/js/7511.a52b23cb.js","8173","static/js/8173.582c8c90.js","613","static/js/613.da2777c4.js","9756","static/js/9756.65c7d9ea.js","97","static/js/97.c5459b6e.js","2649","static/js/2649.4d01838c.js","1857","static/js/1857.a01744c0.js","280","static/js/280.07f8eb1b.js","9123","static/js/9123.0b9c8079.js","6387","static/js/app/items/%5Bslug%5D/page.e8e51342.js"],"default"]
13:Td3b,{"@context":"https://schema.org/","@type":"Dataset","name":"Synthetic dataset - Hospitalised patients with Thromboembolic diagnosis","description":"Background \n\n​Annually in the UK, around 60,000 people develop a pulmonary embolism (PE) and 200,000 a deep vein thrombosis (DVT) and the number of emergency admissions for suspected PE and DVT is increasing. Diagnosing PE and DVT remains a challenge due to the non-specific nature of presenting symptoms. Further tests are often required and each year the number of CTPAs and USS performed for suspected VTE increases. \n\nThere is great interest in finding better tools to identify those with the highest likelihood of a DVT and PE, so that precious screening services can be focused where needed most. A number of tools have been suggested but few have been adopted in clinical practice. \n\nMethods such as age-adjusted D-dimer tests and 4PEPs and 4D scores aim to predict PE and DVT more accurately. Implementing a more precise system could revolutionise how we diagnose and treat these dangerous conditions. This dataset enables an exploration of VTE to better understand disease, identify patients at most risk of the poorest outcomes and to improve health services through the development of new prognostic tools.  \n\nPIONEER geography: The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, and 2,750 beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health.”  \n\nMethodology: A specific pipeline was designed for the generation of the synthetic version of thromboembolic events dataset including data pre-processing, synthetising, and post-process steps. In brief, a generative adversarial network model (CTGAN) in the SDV package (N. Patki, 2016) was employed to generate synthetic dataset which is statistically equivalent to a real dataset. Pre-process and post-process steps were customised to improve the realisticity of the synthetic data. \n\nScope: Enabling data-driven research and machine learning models towards improving the diagnosis of Thromboembolic events (PE/DVT). Real-world dataset linked. The dataset includes large patient demographics, clinical scores, and medical conditions for PE/DVT patients, alongside outcomes taken from ICD-10 & SNOMED-CT codes. \n\nAvailable supplementary data: real-world PE/DVT cohort. \n\nAvailable supplementary support: Analytics, model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.","url":"https://harmonydata.ac.uk/search/items/synthetic-dataset-hospitalised-patients-with-thromboembolic-diagnosis","identifier":[],"keywords":["Morbidities","Thromoboembolic","Clinical outcomes","Acute","DVT","PE","Emergency admmissions","NEWS2 Score","Synthetic dataset"],"temporalCoverage":"2016-12-26T00:00:00.000Z/2021-12-28T00:00:00.000Z","publisher":[{"@type":"Organization","name":"PIONEER: HDR UK Health Data Hub in Acute Care"}]}15:Tadd,Background 

​Annually in the UK, around 60,000 people develop a pulmonary embolism (PE) and 200,000 a deep vein thrombosis (DVT) and the number of emergency admissions for suspected PE and DVT is increasing. Diagnosing PE and DVT remains a challenge due to the non-specific nature of presenting symptoms. Further tests are often required and each year the number of CTPAs and USS performed for suspected VTE increases. 

There is great interest in finding better tools to identify those with the highest likelihood of a DVT and PE, so that precious screening services can be focused where needed most. A number of tools have been suggested but few have been adopted in clinical practice. 

Methods such as age-adjusted D-dimer tests and 4PEPs and 4D scores aim to predict PE and DVT more accurately. Implementing a more precise system could revolutionise how we diagnose and treat these dangerous conditions. This dataset enables an exploration of VTE to better understand disease, identify patients at most risk of the poorest outcomes and to improve health services through the development of new prognostic tools.  

PIONEER geography: The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, and 2,750 beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health.”  

Methodology: A specific pipeline was designed for the generation of the synthetic version of thromboembolic events dataset including data pre-processing, synthetising, and post-process steps. In brief, a generative adversarial network model (CTGAN) in the SDV package (N. Patki, 2016) was employed to generate synthetic dataset which is statistically equivalent to a real dataset. Pre-process and post-process steps were customised to improve the realisticity of the synthetic data. 

Scope: Enabling data-driven research and machine learning models towards improving the diagnosis of Thromboembolic events (PE/DVT). Real-world dataset linked. The dataset includes large patient demographics, clinical scores, and medical conditions for PE/DVT patients, alongside outcomes taken from ICD-10 & SNOMED-CT codes. 

Available supplementary data: real-world PE/DVT cohort. 

Available supplementary support: Analytics, model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.a:[["$","$L12",null,{"strategy":"beforeInteractive","id":"structured-data","type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"$13"}}],["$","$L14",null,{"dataset":{"title":"Synthetic dataset - Hospitalised patients with Thromboembolic diagnosis","description":"$15","image":"$undefined","publisher":{"name":"PIONEER: HDR UK Health Data Hub in Acute Care","url":"$undefined","logo":"$undefined"},"funders":"$undefined","geographicCoverage":"GB","temporalCoverage":"2016-12-26T00:00:00.000Z/2021-12-28T00:00:00.000Z","ageCoverage":"$undefined","studyDesign":[],"resourceType":"dataset","topics":["Morbidities","Thromoboembolic","Clinical outcomes","Acute","DVT","PE","Emergency admmissions","NEWS2 Score","Synthetic dataset"],"instruments":[],"dataCatalogs":[{"name":"Health Data Research Innovation Gateway","url":"https://healthdatagateway.org/en/dataset/167","logo":"$undefined"}],"matchedVariables":[],"allVariables":[{"name":"Synthetic","description":"Unique identifier for the spell"}],"additionalLinks":["https://healthdatagateway.org/en/dataset/167"],"child_datasets":[],"aiSummary":null}}]]
10:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}]]
16:Tadd,Background 

​Annually in the UK, around 60,000 people develop a pulmonary embolism (PE) and 200,000 a deep vein thrombosis (DVT) and the number of emergency admissions for suspected PE and DVT is increasing. Diagnosing PE and DVT remains a challenge due to the non-specific nature of presenting symptoms. Further tests are often required and each year the number of CTPAs and USS performed for suspected VTE increases. 

There is great interest in finding better tools to identify those with the highest likelihood of a DVT and PE, so that precious screening services can be focused where needed most. A number of tools have been suggested but few have been adopted in clinical practice. 

Methods such as age-adjusted D-dimer tests and 4PEPs and 4D scores aim to predict PE and DVT more accurately. Implementing a more precise system could revolutionise how we diagnose and treat these dangerous conditions. This dataset enables an exploration of VTE to better understand disease, identify patients at most risk of the poorest outcomes and to improve health services through the development of new prognostic tools.  

PIONEER geography: The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, and 2,750 beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health.”  

Methodology: A specific pipeline was designed for the generation of the synthetic version of thromboembolic events dataset including data pre-processing, synthetising, and post-process steps. In brief, a generative adversarial network model (CTGAN) in the SDV package (N. Patki, 2016) was employed to generate synthetic dataset which is statistically equivalent to a real dataset. Pre-process and post-process steps were customised to improve the realisticity of the synthetic data. 

Scope: Enabling data-driven research and machine learning models towards improving the diagnosis of Thromboembolic events (PE/DVT). Real-world dataset linked. The dataset includes large patient demographics, clinical scores, and medical conditions for PE/DVT patients, alongside outcomes taken from ICD-10 & SNOMED-CT codes. 

Available supplementary data: real-world PE/DVT cohort. 

Available supplementary support: Analytics, model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.17:Tadd,Background 

​Annually in the UK, around 60,000 people develop a pulmonary embolism (PE) and 200,000 a deep vein thrombosis (DVT) and the number of emergency admissions for suspected PE and DVT is increasing. Diagnosing PE and DVT remains a challenge due to the non-specific nature of presenting symptoms. Further tests are often required and each year the number of CTPAs and USS performed for suspected VTE increases. 

There is great interest in finding better tools to identify those with the highest likelihood of a DVT and PE, so that precious screening services can be focused where needed most. A number of tools have been suggested but few have been adopted in clinical practice. 

Methods such as age-adjusted D-dimer tests and 4PEPs and 4D scores aim to predict PE and DVT more accurately. Implementing a more precise system could revolutionise how we diagnose and treat these dangerous conditions. This dataset enables an exploration of VTE to better understand disease, identify patients at most risk of the poorest outcomes and to improve health services through the development of new prognostic tools.  

PIONEER geography: The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, and 2,750 beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health.”  

Methodology: A specific pipeline was designed for the generation of the synthetic version of thromboembolic events dataset including data pre-processing, synthetising, and post-process steps. In brief, a generative adversarial network model (CTGAN) in the SDV package (N. Patki, 2016) was employed to generate synthetic dataset which is statistically equivalent to a real dataset. Pre-process and post-process steps were customised to improve the realisticity of the synthetic data. 

Scope: Enabling data-driven research and machine learning models towards improving the diagnosis of Thromboembolic events (PE/DVT). Real-world dataset linked. The dataset includes large patient demographics, clinical scores, and medical conditions for PE/DVT patients, alongside outcomes taken from ICD-10 & SNOMED-CT codes. 

Available supplementary data: real-world PE/DVT cohort. 

Available supplementary support: Analytics, model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.18:Tadd,Background 

​Annually in the UK, around 60,000 people develop a pulmonary embolism (PE) and 200,000 a deep vein thrombosis (DVT) and the number of emergency admissions for suspected PE and DVT is increasing. Diagnosing PE and DVT remains a challenge due to the non-specific nature of presenting symptoms. Further tests are often required and each year the number of CTPAs and USS performed for suspected VTE increases. 

There is great interest in finding better tools to identify those with the highest likelihood of a DVT and PE, so that precious screening services can be focused where needed most. A number of tools have been suggested but few have been adopted in clinical practice. 

Methods such as age-adjusted D-dimer tests and 4PEPs and 4D scores aim to predict PE and DVT more accurately. Implementing a more precise system could revolutionise how we diagnose and treat these dangerous conditions. This dataset enables an exploration of VTE to better understand disease, identify patients at most risk of the poorest outcomes and to improve health services through the development of new prognostic tools.  

PIONEER geography: The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, and 2,750 beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health.”  

Methodology: A specific pipeline was designed for the generation of the synthetic version of thromboembolic events dataset including data pre-processing, synthetising, and post-process steps. In brief, a generative adversarial network model (CTGAN) in the SDV package (N. Patki, 2016) was employed to generate synthetic dataset which is statistically equivalent to a real dataset. Pre-process and post-process steps were customised to improve the realisticity of the synthetic data. 

Scope: Enabling data-driven research and machine learning models towards improving the diagnosis of Thromboembolic events (PE/DVT). Real-world dataset linked. The dataset includes large patient demographics, clinical scores, and medical conditions for PE/DVT patients, alongside outcomes taken from ICD-10 & SNOMED-CT codes. 

Available supplementary data: real-world PE/DVT cohort. 

Available supplementary support: Analytics, model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.e:[["$","meta","0",{"charSet":"utf-8"}],["$","title","1",{"children":"Synthetic dataset - Hospitalised patients with Thromboembolic diagnosis"}],["$","meta","2",{"name":"description","content":"$16"}],["$","meta","3",{"property":"og:title","content":"Synthetic dataset - Hospitalised patients with Thromboembolic diagnosis"}],["$","meta","4",{"property":"og:description","content":"$17"}],["$","meta","5",{"property":"og:url","content":"https://harmonydata.ac.uk/search/items/synthetic-dataset-hospitalised-patients-with-thromboembolic-diagnosis"}],["$","meta","6",{"property":"og:site_name","content":"Academic Resource Discovery"}],["$","meta","7",{"property":"og:locale","content":"en_US"}],["$","meta","8",{"property":"og:image","content":"https://harmonydata.ac.uk/search/harmony.png"}],["$","meta","9",{"property":"og:image:width","content":"1200"}],["$","meta","10",{"property":"og:image:height","content":"630"}],["$","meta","11",{"property":"og:image:alt","content":"Synthetic dataset - Hospitalised patients with Thromboembolic diagnosis"}],["$","meta","12",{"property":"og:type","content":"website"}],["$","meta","13",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","14",{"name":"twitter:title","content":"Synthetic dataset - Hospitalised patients with Thromboembolic diagnosis"}],["$","meta","15",{"name":"twitter:description","content":"$18"}],["$","meta","16",{"name":"twitter:image","content":"https://harmonydata.ac.uk/search/harmony.png"}],["$","link","17",{"rel":"icon","href":"/search/favicon.ico","type":"image/x-icon","sizes":"16x16"}]]
c:null
